Biobot Surgical
$8.5M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Biobot Surgical is currently valued at N/A as of April 14, 2025. The company has raised a total of $38.7M in funding.
Investment Perspective
Biobot Surgical's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Biobot Surgical Worth in 2025?
As of 2025, Biobot Surgical is valued at N/A, based on the company's Later Stage VC funding round in April 14, 2025. This valuation positions Biobot Surgical as one of the leading private companies in the sector.
Biobot Surgical Valuation History
Biobot Surgical's funding history demonstrates steady growth and investor confidence.
How Biobot Surgical Valuation is Determined
Private company valuations like Biobot Surgical's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Biobot Surgical Valuation FAQs
Is Biobot Surgical profitable?
Biobot Surgical has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Biobot Surgical's valuation compare to competitors?
Biobot Surgical is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Biobot Surgical IPO?
Biobot Surgical has not announced plans for an initial public offering. Until an IPO, investors can access Biobot Surgical shares through secondary market platforms.